Inotiv, Inc. (NOTV)
NASDAQ: NOTV · Real-Time Price · USD
2.210
+0.060 (2.79%)
At close: Mar 31, 2025, 4:00 PM
2.172
-0.038 (-1.71%)
After-hours: Mar 31, 2025, 7:55 PM EDT
Inotiv Revenue
Inotiv had revenue of $119.88M in the quarter ending December 31, 2024, a decrease of -11.53%. This brings the company's revenue in the last twelve months to $475.11M, down -18.81% year-over-year. In the fiscal year ending September 30, 2024, Inotiv had annual revenue of $490.74M, down -14.27%.
Revenue (ttm)
$475.11M
Revenue Growth
-18.81%
P/S Ratio
0.12
Revenue / Employee
$228,971
Employees
2,075
Market Cap
74.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 490.74M | -81.69M | -14.27% |
| Sep 30, 2023 | 572.43M | 24.77M | 4.52% |
| Sep 30, 2022 | 547.66M | 458.05M | 511.19% |
| Sep 30, 2021 | 89.61M | 29.14M | 48.18% |
| Sep 30, 2020 | 60.47M | 16.85M | 38.64% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
NOTV News
- 7 weeks ago - Inotiv, Inc. (NOTV) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025 - GlobeNewsWire
- 3 months ago - Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million - GlobeNewsWire
- 3 months ago - Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million - GlobeNewsWire
- 3 months ago - Inotiv, Inc. Launches Proposed Public Offering of Common Shares - GlobeNewsWire
- 4 months ago - Inotiv, Inc. (NOTV) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update - GlobeNewsWire
- 4 months ago - Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™ - GlobeNewsWire